Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

NIH to fund UCLA alcoholism study of MediciNova's MN-166

Aug. 26, 2013

Lightlake Therapeutics and NIH partner to develop intranasal naloxone for opioid overdose

Aug. 22, 2013

Atlantic Pharmaceuticals completes pre-IND meeting with FDA for abuse-deterrent hydrocodone

Aug. 16, 2013

Orexo begins dosing in two trials evaluating early and long-term treatment with Zubsolv

Aug. 8, 2013

BioDelivery Sciences submits NDA to FDA for Bunavail

Aug. 2, 2013

Signature Therapeutics receives award to advance abuse-deterrent oxycodone

Aug. 2, 2013

Invion begins phase II INV-102 trial

July 26, 2013

Novel drug and drug target for the treatment of addictive disorders characterized

July 24, 2013

Pluristem's PLX cells tested for treatment of radiation poisoning

July 17, 2013

Novel kappa receptor antagonists disclosed by Research Triangle Institute

July 1, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...